×
验证码:
换一张
Forgotten Password?
Stay signed in
Login With UMPASS
English
|
繁體
Login With UMPASS
Log In
ALL
ORCID
TI
AU
PY
SU
KW
TY
JN
DA
IN
PB
FP
ST
SM
Study Hall
Image search
Paste the image URL
Home
Faculties & Institutes
Scholars
Publications
Subjects
Statistics
News
Search in the results
Faculties & Institutes
Institute of Chi... [2]
THE STATE KEY LA... [2]
INSTITUTE OF APP... [1]
Faculty of Healt... [1]
Faculty of Scien... [1]
Authors
TAM KIN YIP [1]
CHEN MEIWAN [1]
TANG ZIKANG [1]
QU SONGNAN [1]
YU HUA [1]
Document Type
Journal article [4]
Review article [1]
Date Issued
2023 [1]
2021 [2]
2018 [2]
Language
英語English [5]
Source Publication
Chemical Enginee... [1]
INTERNATIONAL JO... [1]
International Jo... [1]
Journal of Drug ... [1]
Materials Chemis... [1]
Indexed By
SCIE [4]
Funding Organization
Funding Project
×
Knowledge Map
UM
Start a Submission
Submissions
Unclaimed
Claimed
Attach Fulltext
Bookmarks
Browse/Search Results:
1-5 of 5
Help
Selected(
0
)
Clear
Items/Page:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
Sort:
Select
Issue Date Ascending
Issue Date Descending
Title Ascending
Title Descending
Author Ascending
Author Descending
WOS Cited Times Ascending
WOS Cited Times Descending
Submit date Ascending
Submit date Descending
Journal Impact Factor Ascending
Journal Impact Factor Descending
Tuning the photothermal properties of carbon dots in the deep-red to near-infrared wavelength regions for tumor therapy
Review article
2023
Authors:
Zhang,Tesen
;
Wu,Jun
;
Tang,Zikang
;
Qu,Songnan
Favorite
|
TC[WOS]:
9
TC[Scopus]:
7
IF:
6.0
/
6.0
|
Submit date:2023/08/03
Cancer-therapy
Emission
Chemotherapy
Combination
Absorption
Shift
Multi-functionalized dendrimers for targeted co-delivery of sorafenib and paclitaxel in liver cancers
Journal article
Ma, Guanglan, Du, Xiao, Zhu, Jianping, Xu, Feng, Yu, Hua, Li, Juan. Multi-functionalized dendrimers for targeted co-delivery of sorafenib and paclitaxel in liver cancers[J]. Journal of Drug Delivery Science and Technology, 2021, 63(102493).
Authors:
Ma, Guanglan
;
Du, Xiao
;
Zhu, Jianping
;
Xu, Feng
;
Yu, Hua
; et al.
Favorite
|
TC[WOS]:
19
TC[Scopus]:
23
IF:
4.5
/
4.7
|
Submit date:2021/12/08
Liver Cancer
Combination Chemotherapy
Nanomedicine
Micelles
Metastasis
Photodynamic creation of artificial tumor microenvironments to collectively facilitate hypoxia-activated chemotherapy delivered by coagulation-targeting liposomes
Journal article
Wang, Chunjie, Liang, Chao, Hao, Yu, Dong, Ziliang, Zhu, Yujie, Li, Quguang, Liu, Zhuang, Feng, Liangzhu, Chen, Meiwan. Photodynamic creation of artificial tumor microenvironments to collectively facilitate hypoxia-activated chemotherapy delivered by coagulation-targeting liposomes[J]. Chemical Engineering Journal, 2021, 414, 128731.
Authors:
Wang, Chunjie
;
Liang, Chao
;
Hao, Yu
;
Dong, Ziliang
;
Zhu, Yujie
; et al.
Favorite
|
TC[WOS]:
15
TC[Scopus]:
17
IF:
13.3
/
13.2
|
Submit date:2021/12/08
Artificial Tumor Microenvironment
Coagulation-targeting Liposome
Combination Cancer Therapy
Enhanced Tumor Accumulation
Hypoxia Activated Chemotherapy
Combination strategies using EGFR-TKi in NSCLC therapy: Learning from the gap between pre-clinical results and clinical outcomes
Journal article
Yang,Zheng, Tam,Kin Yip. Combination strategies using EGFR-TKi in NSCLC therapy: Learning from the gap between pre-clinical results and clinical outcomes[J]. International Journal of Biological Sciences, 2018, 14(2), 204-216.
Authors:
Yang,Zheng
;
Tam,Kin Yip
Favorite
|
TC[WOS]:
74
TC[Scopus]:
81
IF:
8.2
/
8.3
|
Submit date:2021/03/04
Chemotherapy
Combination
Egfr-tki
Immunotherapy
Nsclc
Targeted Therapy
Combination Strategies Using EGFR-TKi in NSCLC Therapy: Learning from the Gap between Pre-Clinical Results and Clinical Outcomes
Journal article
Yang, Zheng, Tam, Kin Yip. Combination Strategies Using EGFR-TKi in NSCLC Therapy: Learning from the Gap between Pre-Clinical Results and Clinical Outcomes[J]. INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES, 2018, 14(2), 204-216.
Authors:
Yang, Zheng
;
Tam, Kin Yip
Favorite
|
TC[WOS]:
74
TC[Scopus]:
81
IF:
8.2
/
8.3
|
Submit date:2018/10/30
Combination
Egfr-tki
Nsclc
Chemotherapy
Targeted Therapy
Immunotherapy